1. Home
  2. LIMNW vs GAB Comparison

LIMNW vs GAB Comparison

Compare LIMNW & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIMNW
  • GAB
  • Stock Information
  • Founded
  • LIMNW N/A
  • GAB 1986
  • Country
  • LIMNW United States
  • GAB United States
  • Employees
  • LIMNW N/A
  • GAB N/A
  • Industry
  • LIMNW
  • GAB Investment Managers
  • Sector
  • LIMNW
  • GAB Finance
  • Exchange
  • LIMNW Nasdaq
  • GAB Nasdaq
  • Market Cap
  • LIMNW N/A
  • GAB N/A
  • IPO Year
  • LIMNW N/A
  • GAB N/A
  • Fundamental
  • Price
  • LIMNW $0.09
  • GAB $5.77
  • Analyst Decision
  • LIMNW
  • GAB
  • Analyst Count
  • LIMNW 0
  • GAB 0
  • Target Price
  • LIMNW N/A
  • GAB N/A
  • AVG Volume (30 Days)
  • LIMNW N/A
  • GAB 667.8K
  • Earning Date
  • LIMNW N/A
  • GAB 01-01-0001
  • Dividend Yield
  • LIMNW N/A
  • GAB 10.91%
  • EPS Growth
  • LIMNW N/A
  • GAB N/A
  • EPS
  • LIMNW N/A
  • GAB N/A
  • Revenue
  • LIMNW N/A
  • GAB N/A
  • Revenue This Year
  • LIMNW N/A
  • GAB N/A
  • Revenue Next Year
  • LIMNW N/A
  • GAB N/A
  • P/E Ratio
  • LIMNW N/A
  • GAB N/A
  • Revenue Growth
  • LIMNW N/A
  • GAB N/A
  • 52 Week Low
  • LIMNW N/A
  • GAB $4.56
  • 52 Week High
  • LIMNW N/A
  • GAB $5.88
  • Technical
  • Relative Strength Index (RSI)
  • LIMNW N/A
  • GAB 61.18
  • Support Level
  • LIMNW N/A
  • GAB $5.72
  • Resistance Level
  • LIMNW N/A
  • GAB $5.79
  • Average True Range (ATR)
  • LIMNW 0.00
  • GAB 0.06
  • MACD
  • LIMNW 0.00
  • GAB -0.01
  • Stochastic Oscillator
  • LIMNW 0.00
  • GAB 76.92

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: